Systematic Screening for PTSD: The First Obstacle to (and Opportunity for) Implementing Trauma-Informed Practice in a Substance Use Clinic
Live, virtual CME training through WebEx Hosted by: Maryland Addiction Consultation Service (MACS)
Audience: Primary Care Physicians, Advance Practice Registered Nurses, Physician Assistants, other members of the healthcare team
Learning Objectives:
1. Define trauma and trauma-related disorders
2. Identify 2 ways in which trauma-related and substance use symptoms can be related
3. Describe 1 efficient, well-tolerated evidence-based screening tool for PTSD
4. Identify 3 helpful ways in which a clinician can respond to a positive PTSD screen during addictions treatment
Presenter: Benjamin Israel, MD
Consultant, Maryland Addiction Consultation Service (MACS)
Assistant Professor at the University of Maryland School of Medicine, Department of Psychiatry
Disclosure Information: The planners and reviewers for this activity have reported no relevant financial relationships to disclose.
Event contact: Bridget Sweeney, MACS Training Coordinator
MACSTraining@som.umaryland.edu
CME Credit:
“This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society and the Maryland Health Care Commission (MHCC). MedChi is accredited by the ACCME to provide continuing medical education for physicians. MedChi designates this virtual online educational activity for a maximum of 1
AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
CEU Credit: Maryland Addiction Consultation Service (MACS) of the University of Maryland School of Medicine, Department of Psychiatry is authorized as a sponsor of Continuing Education Units. MACS maintains responsibility for this program.
MAT and MATE Acts: This training counts toward the 8-hour SUD training requirement to renew or get your DEA license. On December 29, 2022, President Biden signed the fiscal year 2023 omnibus, passing the Mainstreaming Addiction Treatment (MAT) and Medication Access and Training Expansion (MATE) Acts. These bills were passed to expand access to buprenorphine for the treatment of opioid use disorder, and normalize and enhance substance use care across healthcare settings. MACS is monitoring guidance from state and federal agencies closely and will update this page when more information becomes available. The resources on this page offer information about the omnibus, the bills, and the implications for healthcare providers and programs. Find out more here:
https://www.marylandmacs.org/MAT--MATE-Acts/